Published September 30, 2019
| Version v1
Dataset
Open
Table 2 h AChE, h in Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease
Authors/Creators
- 1. ∗ & ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05, Hradec Králové, Czech & Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic
Description
Table 2 h AChE, h BuChE, POP and GSK-3β inhibitory activities of the tested Amaryllidaceae alkaloids isolated from Narcissus pseudonarcissus cv. Dutch Master expressed as IC50.
| Compound | h AChE IC (μM) a 50 | h BuChE IC (μM) a 50 | SI for h AChE b | POP IC a (μM) 50 | GSK-3β (% inhib.) c | GSK-3β IC a (μM) 50 |
|---|---|---|---|---|---|---|
| Homolycorine (1) | 64 ± 4 | 151 ± 20 | 2.4 | 173 ± 41 | 54 ± 1 | n.d. |
| Masonine (2) | 305 ± 34 | 229 ± 24 | 0.8 | 314 ± 34 | 66 ± 4 | 27.9 ± 0.8 |
| Seco-isopowellaminone (3) | 294 ± 33 | > 500 | > 1.7 | > 500 | 38 ± 1 | n.d. |
| O -Ethyllycorenine (4) | > 500 | > 500 | n.d. | > 500 | 58 ± 3 | n.d. |
| N -Demethylmasonine (5) | > 500 | 474 ± 13 | <0.9 | > 500 | n.d. | n.d. |
| Narcimatuline (6) | 489 ± 60 | 5.9 ± 0.2 | 0.01 | 29.2 ± 1.0 | 67 ± 3 | 20.7 ± 2.4 |
| O -Acetylpluviine (7) | > 500 | > 500 | n.d. | n.d. | n.d. | n.d. |
| Tazettine (8) | > 500 | > 500 | n.d. | > 500 | 49 ± 0 | n.d. |
| Galanthine (9) | 606 ± 60 | > 500 | > 1.7 | > 500 | 26 ± 7 | n.d. |
| Galanthamine (10) | 1.7 ± 0.1 | 42.3 ± 1.3 | 24.9 | > 500 | n.d. | n.d. |
| Narwedine (11) | 281 ± 34 | 911 ± 69 | 3.2 | 907 ± 87 | n.d. | n.d. |
| Caranine (12) | 321 ± 42 | 487 ± 55 | 1.5 | > 1000 | 58 ± 9 | 30.8 ± 0.3 |
| Lycoraminone (13) | > 500 | > 500 | n.d. | n.d. | 39 ± 1 | n.d. |
| Lycoramine (14) | 456 ± 57 | > 500 | > 1.1 | > 500 | n.d. | n.d. |
| O -Methyllycorenine (15) | > 500 | > 500 | n.d. | > 500 | n.d. | n.d. |
| Lycorenine (16) | > 500 | > 500 | n.d. | > 500 | 48 ± 3 | n.d. |
| Oduline (17) | > 500 | > 500 | n.d. | 252 ± 27 | 58 ± 4 | n.d. |
| Haemanthamine (18) | > 500 | > 500 | n.d. | > 500 | 52 ± 0 | n.d. |
| Tetrahydromasonine (19) | > 500 | > 500 | n.d. | > 500 | 22 ± 0 | n.d. |
| Hippeastrine (20) | > 500 | > 500 | n.d. | > 500 | 11 ± 2 | n.d. |
| Crinine (21) | > 500 | > 500 | n.d. | > 500 | 40 ± 5 | n.d. |
| Epimaritidine (22) | > 500 | > 500 | n.d. | n.d. | n.d. | n.d. |
| Huperzine A c | 0.033 ± 0.001 | > 500 | > 15.151 | n.d. | n.d. | n.d. |
| Berberine c | n.d. | n.d. | n.d. | 142 ± 21 | n.d. | n.d. |
| Z -Pro-prolinal c | n.d. | n.d. | n.d. | 2.75 × 10−3 | n.d. | n.d. |
| SB-415286 c | n.d. | n.d. | n.d. | n.d. | n.d. | 70 nM |
a Compound concentration required to decrease enzyme activity by 50%; the values are the mean ± SEM of three independent measurements, each performed in triplicate; b Selectivity index (SI) for h AChE is determined as ratio h BuChE IC / h AChE IC; c tested at 10 μM compound concentration; n.d. stands for not determined.
Notes
Files
Files
(5.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:2e0dddbce938e47048bbcdcfcc9a1beb
|
5.3 kB | Download |
System files
(13.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:63bd8b0309f2e29eb697b5bb491e6549
|
13.5 kB | Download |